By Caroline Valetkevitch
(Reuters) - U.S. stocks rose on Monday, with utilities leading a rebound on the S&P after three weeks of losses, as a decline in the U.S. dollar against the euro eased some worries over how a robust greenback might erode the earnings of multinationals.
The dollar fell across the board Monday on investor concerns its recent strength could prompt the Federal Reserve to be more cautious about raising interest rates this year.
The S&P utilities index <.SPLRCU>, which tends to do well in a low interest rate environment, was up 2.1 percent, leading the day's gains.
The next statement from the Fed is due on Wednesday, when investors expect the central bank to give a clearer signal on the timing of its first interest rate hike in almost a decade.
"It's just a little bit of relief from last week's selloff," said Joseph Benanti, managing director, sales and trading of Rosenblatt Securities in New York.
The S&P healthcare sector <.SPXHC> was up 1.9 percent, helped by a 3.6 percent price increase in shares of Amgen
Salix Pharmaceuticals
At 1:19 p.m., the Dow Jones industrial average <.DJI> rose 176.44 points, or 0.99 percent, to 17,925.75, the S&P 500 <.SPX> gained 19.9 points, or 0.97 percent, to 2,073.3 and the Nasdaq Composite <.IXIC> added 38.22 points, or 0.78 percent, to 4,909.98.
The S&P 500 has fallen 2.7 percent in the last three weeks, including a 0.9 percent drop last week. The Dow lost 0.6 percent last week while the Nasdaq declined 1.1 percent.
Energy shares also rose despite further losses in oil prices. The S&P energy index <.SPNY> was up 0.5 percent.
The biggest percentage decliner in the S&P 500 was Avon Products
Advancing issues outnumbered declining ones on the NYSE by 1,831 to 1,164, for a 1.57-to-1 ratio on the upside; on the Nasdaq, 1,442 issues rose and 1,236 fell for a 1.17-to-1 ratio favoring advancers.
The benchmark S&P 500 index was posting 50 new 52-week highs and 10 new lows; the Nasdaq Composite was recording 142 new highs and 50 new lows.
(Additional reporting by Sinead Carew; Editing by Bernadette Baum)
Relacionados
- El museo de la Bauhaus redefine su colección permanente con 100 nuevos objetos
- La USC se une a Laboratorios Esteve para investigar durante tres años nuevos fármacos contra el dolor crónico
- Así son los nuevos medicamentos que podrían reducir a la mitad el riesgo de sufrir un infarto
- El secretario general de Política de Defensa diserta en la UPO ante los nuevos retos de la seguridad global
- Así es la Ley Habilitante, el instrumento que da nuevos poderes a Maduro en Venezuela